Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors - Concepedia

Concepedia

Publication | Open Access

Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

DOI Full Paper Access

28

Citations

27

References

2020

Year

Vivek Subbiah, William D. Erwin, Osama Mawlawi, Asa McCoy, David Wages, Catherine Wheeler, Carlos González-Lepera, Holly Liu, Homer A. Macapinlac, Funda Meric‐Bernstam,

Clinical Cancer Research

Abstract

The favorable safety profile and initial antitumor activity observed for <sup>90</sup>Y-FF-21101 warrant further evaluation of this radioimmunotherapeutic (RIT) approach and provide initial clinical data supporting P-cadherin as a potential target for cancer treatment.

References

	Year	Citations

Page 1